Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)
8.55
+0.18 (2.15%)
Sep 30, 2026, 3:04 PM CST
SHE:002349 Revenue
Jinghua Pharmaceutical Group had revenue of 375.01M CNY in the quarter ending June 30, 2026, with 1.94% growth. This brings the company's revenue in the last twelve months to 1.48B, up 4.96% year-over-year. In the year 2025, Jinghua Pharmaceutical Group had annual revenue of 1.46B with 4.13% growth.
Revenue (ttm)
1.48B
Revenue Growth
+4.96%
P/S Ratio
4.78
Revenue / Employee
1.01M
Employees
1,462
Market Cap
7.09B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.46B | 57.87M | 4.13% |
| Dec 31, 2024 | 1.40B | -109.66M | -7.25% |
| Dec 31, 2023 | 1.51B | -61.31M | -3.90% |
| Jan 1, 2023 | 1.57B | 215.19M | 15.85% |
| Jan 1, 2022 | 1.36B | 76.51M | 5.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| China Animal Husbandry Industry | 6.58B |
| Northeast Pharmaceutical Group | 6.56B |
| Renhe Pharmacy Co.,Ltd | 3.65B |
| Jiangsu Kanion Pharmaceutical | 3.31B |
| Jiuzhitang | 2.60B |
| Hubei Hongyuan Pharmaceutical Technology | 2.40B |
| Guilin Sanjin Pharmaceutical | 2.02B |
| Guangxi Wuzhou Zhongheng Group | 1.44B |